Cardiovascular Drugs and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 70.0% | 1.016 | Q1 | 84.3% |
| 2024 | 3.1 | Q2 | 70.0% | 1.002 | Q1 | 84.3% |
| 2023 | 3.1 | Q2 | 65.9% | 0.973 | Q1 | 84.9% |
| 2022 | 3.4 | Q2 | 62.5% | 0.913 | Q1 | 84.1% |
| 2021 | 3.9 | Q2 | 67.6% | 0.860 | Q1 | 83.1% |
| 2020 | — | — | 1.108 | Q1 | 87.4% | |
| 2019 | — | — | 1.360 | Q1 | 91.3% | |
| 2018 | — | — | 1.338 | Q1 | 90.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0920-3206
ISSN
1573-7241
country
UScoverage
1987-2026